There was less population density then, and medica
Post# of 148168
Gut assessment is lethality will generally remain somewhere in the 5% range for several months still, but I expect R values and transmissibility (through both mutation and seasonal factors) to increase first in localized areas of the Northern Hemisphere and then worldwide. The unknown is to what extent first infection primes host for hyperimmunity on second infection. There's no way to know, but it's very possible the second wave of the 1918 flu was so much worse due to that, and not a massive mutation / genotypic shift towards lethality. Hyperimmunity is also a major issue with vaccine candidates.
Immune modulators are the only realistic, long term solution.